Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.

Moore DM, Awor A, Downing R, Kaplan J, Montaner JS, Hancock J, Were W, Mermin J.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):477-84. doi: 10.1097/QAI.0b013e318186eb18.

PMID:
18989232
2.

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.

Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N.

AIDS. 2006 Aug 1;20(12):1613-9. Erratum in: AIDS. 2006 Aug 22;20(13):1790.

PMID:
16868442
3.

CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.

McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.

Clin Infect Dis. 2005 Dec 1;41(11):1662-70. Epub 2005 Oct 19.

PMID:
16267741
4.

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study..

Clin Infect Dis. 2005 Aug 1;41(3):361-72. Epub 2005 Jun 24.

PMID:
16007534
5.

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.

Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.

HIV Med. 2007 Jan;8(1):46-54.

6.

Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.

Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9.

PMID:
17019367
7.

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.

Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):553-8. doi: 10.1097/QAI.0b013e31816856c5.

PMID:
18285713
8.

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.

J Infect Dis. 2006 Jul 1;194(1):29-37. Epub 2006 May 18.

PMID:
16741879
9.

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.

PMID:
19474468
10.

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

Bishai D, Colchero A, Durack DT.

AIDS. 2007 Jun 19;21(10):1333-40.

PMID:
17545710
11.

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.

Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC; Swiss HIV Cohort Study..

Antivir Ther. 2007;12(6):889-97.

PMID:
17926643
12.

The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.

Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.

PMID:
18419499
13.

Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.

Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, Downing R, Mermin J, Weidle PJ.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):578-83.

PMID:
15793369
14.

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, Wood R.

Antivir Ther. 2007;12(1):83-8.

PMID:
17503751
15.

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study..

Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Erratum in: Clin Infect Dis. 2009 May 15;48(10):1491.

PMID:
18783328
16.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.

Diomandé FV, Bissagnéné E, Nkengasong JN, Maurice C, Monga B, Laga M, Nolan ML.

AIDS. 2003 Jul;17 Suppl 3:S87-93.

PMID:
14565614
17.

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM; AIDS Clinical Trials Group 5170 Study Team..

J Infect Dis. 2007 May 15;195(10):1426-36. Epub 2007 Apr 6.

PMID:
17436222
18.

Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents.

Kaplan JE, Hanson DL, Jones JL, Dworkin MS; Adult and Adolescent Spectrum of HIV Disease Project Investigators..

AIDS. 2001 Sep 28;15(14):1831-6.

PMID:
11579245
19.

Dissociation of CD4(+) cell counts from viral load and association with immune complexes in HIV(+) hemophilia patients.

Sadeghi M, Daniel V, Naujokat C, Süsal C, Weimer R, Huth-Kühne A, Zimmermann R, Opelz G.

Immunol Lett. 2004 Jan 30;91(1):23-32.

PMID:
14757366
20.

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, Hirsch MS, Shafer RW, Robbins GK, Pollard RB; ACTG 384 Team..

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):426-34.

PMID:
16810109

Supplemental Content

Support Center